Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]PBR06 PET in ALS
NCT03876002Phase 1Completed
- Sponsor
- Molecular NeuroImaging
- Start
- Jun 2016
- Primary completion
- Feb 2018
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of [18F]PBR06 in amyotrophic lateral sclerosis (ALS), sponsored by Molecular NeuroImaging. Primary endpoint: Time-activity data at 1 year. Started Jun 2016; status: completed.
02
Drugs
[18F]PBR06
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT03876002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03876002.